Financhill
Back

Apellis Pharmaceuticals, Inc. Vs. Pinnacle Financial Partners, Inc. Industry Stock Comparison

Buy
56

APLS
Apellis Pharmaceuticals, Inc.

Last Price:
$24.57
Seasonality Move:
7.92%
Buy
73

PNFP
Pinnacle Financial Partners, Inc.

Last Price:
$100.40
Seasonality Move:
5.36%
Buy
56
Apellis Pharmaceuticals, Inc. (APLS) is a Buy

Is Apellis Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals, Inc. [APLS] share price is $25.23. The Score for APLS is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • APLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
73
Pinnacle Financial Partners, Inc. (PNFP) is a Buy

Is Pinnacle Financial Partners, Inc. a Buy, Sell or Hold?

  • The current Pinnacle Financial Partners, Inc. [PNFP] share price is $99.88. The Score for PNFP is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
  • PNFP is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

APLS Stock Price Chart

What is Apellis Pharmaceuticals, Inc.'s stock price today?

  • The Apellis Pharmaceuticals, Inc. share price today is $25.23
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

PNFP Stock Price Chart

What is Pinnacle Financial Partners, Inc.'s stock price today?

  • The Pinnacle Financial Partners, Inc. share price today is $99.88
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PNFP is experiencing slight selling pressure.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.69 Buy
Relative Strength Index (14 RSI): 68.46 Buy
Chaikin Money Flow: 1409326 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.36 - 23.18) Buy
Bollinger Bands (100): (20.82 - 26.96) Buy

PNFP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.94 Buy
Relative Strength Index (14 RSI): 71.04 Buy
Chaikin Money Flow: -160910 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (87.15 - 96.43) Buy
Bollinger Bands (100): (87.59 - 96.55) Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 23.69 Buy
20-day SMA: 21.71 Buy
50-day SMA: 23.11 Buy
200-day SMA: 21.92 Buy
8-day EMA: 23.84 Buy
20-day EMA: 22.66 Buy
50-day EMA: 22.73 Buy
200-day EMA: 24.25 Buy

PNFP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 97.49 Buy
20-day SMA: 92.88 Buy
50-day SMA: 89.89 Buy
200-day SMA: 98.99 Buy
8-day EMA: 97.68 Buy
20-day EMA: 94.24 Buy
50-day EMA: 92.29 Buy
200-day EMA: 97.22 Buy

Apellis Pharmaceuticals, Inc. Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.00 per share, and a decrease next year of $1.42 per share.

Pinnacle Financial Partners, Inc. Earnings Growth & PNFP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.60 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.65 per share, and an increase next year of $1.63 per share.

Apellis Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Pinnacle Financial Partners, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):